What is ENDRA Life Sciences Inc.'s market cap?

ENDRA Life Sciences Inc. (NDRA) has a market capitalization of $6.1M and trades on NASDAQ.

Who are ENDRA Life Sciences Inc.'s competitors?

ENDRA Life Sciences Inc.'s key competitors include Medtronic plc, GE Healthcare, Royal Philips, and others. These companies compete in similar markets and product categories.

Who does ENDRA Life Sciences Inc. partner with?

ENDRA Life Sciences Inc.'s notable partners include Arca Investment Management, Anchorage Digital Bank, N.A..

Where is ENDRA Life Sciences Inc. headquartered?

ENDRA Life Sciences Inc. is headquartered in United States of America and employs approximately 21 people. It has been publicly traded since 2017.

ENDRA Life Sciences Inc.

NDRA

ENDRA Life Sciences is a medical technology company developing the TAEUS (Thermo-Acoustic Enhanced Ultrasound) platform, a next-generation diagnostic tool designed to enhance conventional ultrasound.

Market cap

$6.07M+48.5%

Table of contents

Earnings

Q1 2026 report

May 18, 2026

EPS-$1.09Beat by $0.14

Read the full report

Next report

Aug 13, 2026 (In 2 weeks)

Revenue estimate$100.0K

EPS estimate-$0.84

Competitors

By market cap

Medtronic$107.81B-8.5%

GE HealthCare Technologies$27.8B-21.9%

Philips$24.3B+2.4%

NovoCure$2.0B+51.6%

Artivion$1.3B-14.0%

AngioDynamics$564.6M+52.4%

Humacyte$181.8M-52.6%

ENDRA Life Sciences Inc.$6.1M+27.0%

By revenue growth

GE HealthCare Technologies+6.5%

By net margin

Medtronic13.2%-0.7pp

GE HealthCare Technologies9.33%-1.9pp

Artivion2.55%+8.0pp

AngioDynamics-11.48%+0.1pp

NovoCure-21.25%+5.9pp

Profile

ENDRA Life Sciences is a medical technology company developing the TAEUS (Thermo-Acoustic Enhanced Ultrasound) platform, a next-generation diagnostic tool designed to enhance conventional ultrasound. The company's primary focus is providing a non-invasive, point-of-care solution for quantifying liver fat to assess metabolic diseases such as MASLD and MASH. Additionally, the company operates a Digital Asset Treasury initiative to optimize capital preservation through decentralized finance investments.

Competitive position

ENDRA is a pioneer in RF-based thermoacoustic ultrasound, positioning itself as a cost-effective, point-of-care alternative to expensive MRI and invasive biopsy procedures.

GeographiesUnited States, European Union, Canada

Customer segmentsHealthcare Providers, Life Sciences Companies, Clinical Researchers

Business modelSubscription SaaS, Capital Equipment Sales, Licensing, Asset Management

SuppliersContract Manufacturers, Component Suppliers, RF Source Providers, Digital Asset Custodians

CustomersHospitals, Diagnostic Imaging Centers, Pharmaceutical Developers, Metabolic Specialty Clinics

CountryUnited States of America

Listed2017

Employees21.0

CEOAlexander Y. Tokman

SectorHealthcare

IndustryMedical - Diagnostics & Research

Websiteendrainc.com

FilingsSEC EDGAR

Questions, answered.

What is ENDRA Life Sciences Inc.'s market cap?: ENDRA Life Sciences Inc. (NDRA) has a market capitalization of $6.1M and trades on NASDAQ.
Who are ENDRA Life Sciences Inc.'s competitors?: ENDRA Life Sciences Inc.'s key competitors include Medtronic plc, GE Healthcare, Royal Philips, and others. These companies compete in similar markets and product categories.
Who does ENDRA Life Sciences Inc. partner with?: ENDRA Life Sciences Inc.'s notable partners include Arca Investment Management, Anchorage Digital Bank, N.A..
Where is ENDRA Life Sciences Inc. headquartered?: ENDRA Life Sciences Inc. is headquartered in United States of America and employs approximately 21 people. It has been publicly traded since 2017.